Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

Roger Yonchien Tsien (1952-2016).

Rink TJ, Tsien LY, Tsien RW.

Nature. 2016 Oct 13;538(7624):172. doi: 10.1038/538172a. No abstract available.

2.

Can you stand the heat of today's drug discovery?

Rink TJ.

Drug Discov Today. 2000 Jun;5(6):226-227. No abstract available.

PMID:
10825727
3.

A Boston T party.

Rink TJ.

Drug Discov Today. 1999 Jun;4(6):249-250. No abstract available.

PMID:
10354536
4.

Dose-response for glucagonostatic effect of amylin in rats.

Gedulin BR, Rink TJ, Young AA.

Metabolism. 1997 Jan;46(1):67-70.

PMID:
9005972
5.

Comparison of the in vitro and in vivo pharmacology of adrenomedullin, calcitonin gene-related peptide and amylin in rats.

Vine W, Beaumont K, Gedulin B, Pittner R, Moore CX, Rink TJ, Young AA.

Eur J Pharmacol. 1996 Oct 24;314(1-2):115-21.

PMID:
8957226
7.

Diabetogenic effects of salmon calcitonin are attributable to amylin-like activity.

Young AA, Wang MW, Gedulin B, Rink TJ, Pittner R, Beaumont K.

Metabolism. 1995 Dec;44(12):1581-9.

PMID:
8786728
9.

Differential antagonism of amylin's metabolic and vascular actions with amylin receptor antagonists.

Beaumont K, Moore CX, Pittner RA, Prickett KS, Gaeta LS, Rink TJ, Young AA.

Can J Physiol Pharmacol. 1995 Jul;73(7):1025-9.

PMID:
8846395
10.

Regulation of muscle glycogen metabolism by CGRP and amylin: CGRP receptors not involved.

Beaumont K, Pittner RA, Moore CX, Wolfe-Lopez D, Prickett KS, Young AA, Rink TJ.

Br J Pharmacol. 1995 Jul;115(5):713-5.

11.

Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injections of amylin.

Young AA, Gedulin B, Vine W, Percy A, Rink TJ.

Diabetologia. 1995 Jun;38(6):642-8.

PMID:
7672483
12.

Amylin and epinephrine have no direct effect on glucose transport in isolated rat soleus muscle.

Pittner RA, Wolfe-Lopez D, Young AA, Rink TJ.

FEBS Lett. 1995 May 22;365(1):98-100.

13.

Genetics. In search of a satiety factor.

Rink TJ.

Nature. 1994 Dec 1;372(6505):406-7. No abstract available.

PMID:
7984230
14.

Selective amylin antagonist suppresses rise in plasma lactate after intravenous glucose in the rat. Evidence for a metabolic role of endogenous amylin.

Young AA, Gedulin B, Gaeta LS, Prickett KS, Beaumont K, Larson E, Rink TJ.

FEBS Lett. 1994 May 2;343(3):237-41.

15.

Molecular physiology of amylin.

Pittner RA, Albrandt K, Beaumont K, Gaeta LS, Koda JE, Moore CX, Rittenhouse J, Rink TJ.

J Cell Biochem. 1994;55 Suppl:19-28. Review.

PMID:
7929615
16.

High affinity amylin binding sites in rat brain.

Beaumont K, Kenney MA, Young AA, Rink TJ.

Mol Pharmacol. 1993 Sep;44(3):493-7.

PMID:
8396712
17.

Response to intravenous injections of amylin and glucagon in fasted, fed, and hypoglycemic rats.

Young AA, Cooper GJ, Carlo P, Rink TJ, Wang MW.

Am J Physiol. 1993 Jun;264(6 Pt 1):E943-50.

PMID:
8333519
18.

Structure and biology of amylin.

Rink TJ, Beaumont K, Koda J, Young A.

Trends Pharmacol Sci. 1993 Apr;14(4):113-8. Review.

PMID:
8516954
20.

Amylin and insulin in rat soleus muscle: dose responses for cosecreted noncompetitive antagonists.

Young AA, Gedulin B, Wolfe-Lopez D, Greene HE, Rink TJ, Cooper GJ.

Am J Physiol. 1992 Aug;263(2 Pt 1):E274-81.

PMID:
1514607
21.

Agonist-evoked Ca2+ entry in human platelets.

Sage SO, Sargeant P, Merritt JE, Mahaut-Smith MP, Rink TJ.

Biochem J. 1992 Jul 1;285 ( Pt 1):341-4. No abstract available.

22.

Amylin concentrations and glucose control.

Koda JE, Fineman M, Rink TJ, Dailey GE, Muchmore DB, Linarelli LG.

Lancet. 1992 May 9;339(8802):1179-80. No abstract available.

PMID:
1349407
23.
24.

Rapid ADP-evoked currents in human platelets recorded with the nystatin permeabilized patch technique.

Mahaut-Smith MP, Sage SO, Rink TJ.

J Biol Chem. 1992 Feb 15;267(5):3060-5.

25.
26.

Amylin is more potent and more effective than glucagon in raising plasma glucose concentration in fasted, anesthetized rats.

Wang MW, Carlo P, Rink TJ, Young AA.

Biochem Biophys Res Commun. 1991 Dec 31;181(3):1288-93.

PMID:
1764079
28.

8-37h-CGRP antagonizes actions of amylin on carbohydrate metabolism in vitro and in vivo.

Wang MW, Young AA, Rink TJ, Cooper GJ.

FEBS Lett. 1991 Oct 21;291(2):195-8.

29.
30.

SK&F 96365, a novel inhibitor of receptor-mediated calcium entry.

Merritt JE, Armstrong WP, Benham CD, Hallam TJ, Jacob R, Jaxa-Chamiec A, Leigh BK, McCarthy SA, Moores KE, Rink TJ.

Biochem J. 1990 Oct 15;271(2):515-22.

31.

Voltage-gated potassium channels and the control of membrane potential in human platelets.

Mahaut-Smith MP, Rink TJ, Collins SC, Sage SO.

J Physiol. 1990 Sep;428:723-35.

32.

Receptor-mediated calcium entry.

Rink TJ.

FEBS Lett. 1990 Aug 1;268(2):381-5. Review.

33.

Receptor-activated single channels in intact human platelets.

Mahaut-Smith MP, Sage SO, Rink TJ.

J Biol Chem. 1990 Jun 25;265(18):10479-83.

34.

Calcium signalling.

Rink TJ, Merritt JE.

Curr Opin Cell Biol. 1990 Apr;2(2):198-205. Review. No abstract available.

PMID:
2163657
35.

The effects of siguazodan, a selective phosphodiesterase inhibitor, on human platelet function.

Murray KJ, England PJ, Hallam TJ, Maguire J, Moores K, Reeves ML, Simpson AW, Rink TJ.

Br J Pharmacol. 1990 Mar;99(3):612-6.

37.

Calcium signaling in human platelets.

Rink TJ, Sage SO.

Annu Rev Physiol. 1990;52:431-49. Review.

PMID:
2158766
39.

Calcium oscillations.

Rink TJ.

Nature. 1989 Jul 27;340(6231):271-2. No abstract available.

PMID:
2787480
40.

Calcium signalling in non-excitable cells: notes on oscillations and store refilling.

Rink TJ, Hallam TJ.

Cell Calcium. 1989 Jul;10(5):385-95. Review.

PMID:
2670242
41.
42.

Calcium oscillations in non-excitable cells.

Rink TJ, Jacob R.

Trends Neurosci. 1989 Feb;12(2):43-6. Review. No abstract available.

PMID:
2469208
43.

Receptor-mediated Ca2+ entry: diversity of function and mechanism.

Hallam TJ, Rink TJ.

Trends Pharmacol Sci. 1989 Jan;10(1):8-10. Review. No abstract available.

PMID:
2556820
44.

Repetitive spikes in cytoplasmic calcium evoked by histamine in human endothelial cells.

Jacob R, Merritt JE, Hallam TJ, Rink TJ.

Nature. 1988 Sep 1;335(6185):40-5.

PMID:
3412458
45.
46.

A real receptor-operated calcium channel?

Rink TJ.

Nature. 1988 Aug 25;334(6184):649-50. No abstract available.

PMID:
2457807
47.

Effects of SK&F 94120, an inhibitor of cyclic nucleotide phosphodiesterase type III, on human platelets.

Simpson AW, Reeves ML, Rink TJ.

Biochem Pharmacol. 1988 Jun 15;37(12):2315-20.

PMID:
2455518
48.

Cytosolic calcium in platelet activation.

Rink TJ.

Experientia. 1988 Feb 15;44(2):97-100. Review.

PMID:
3278926
49.

Measurement of cytosolic calcium: fluorescent calcium indicators.

Rink TJ.

Miner Electrolyte Metab. 1988;14(1):7-14. Review.

PMID:
3279297
50.

Initiation and termination of Ca2+ signals: studies in human platelets.

Rink TJ, Sage SO.

Soc Gen Physiol Ser. 1988;43:381-94. Review. No abstract available.

PMID:
3077556

Supplemental Content

Support Center